BIAF Earnings Date: Nov 18, 2026 (Estimated) — bioAffinity Technologies, Inc.
NASDAQ · Healthcare · Diagnostics & Research
Updated
When is BIAF's next earnings date?
bioAffinity Technologies, Inc. (BIAF) is expected to report Q3 2026 earnings on Wednesday, November 18, 2026 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$31.50 on revenue of $1.9M.
How did BIAF do in its last earnings report?
In its most recent report on Aug 7, 2026 (Q2 2026), bioAffinity Technologies, Inc. posted EPS of -$0.64 versus the -$31.50 estimate, a beat of 98.0%. Revenue was $1.5M against a $1.7M estimate. The stock's 1-day post-earnings move was -3.7%.
How much does BIAF stock move after earnings?
BIAF beat EPS estimates in 3 of its last 6 reported quarters. Over the last 8 reports the stock moved an average of 14.5% (up or down) in the day after earnings.
About bioAffinity Technologies, Inc.
As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lung, a specialized diagnostic test designed for the early identification of lung cancer. Beyond diagnostics, the firm actively explores targeted therapies intended to combat cancer at a cellular level. This San Antonio, Texas-based company commenced operations in 2014.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-07 | Q2 2026 | -31.50 | -0.64 | +97.97% | $1.5M | ✅ Beat | -3.71% | -27.69% | +92.20% |
| 2026-05-08 | Q1 2026 | -2.40 | -0.81 | +66.25% | $1.4M | ✅ Beat | -4.25% | -6.13% | -24.53% |
| 2026-03-13 | Q4 2025 | -2.70 | -1.11 | +58.89% | $1.6M | ✅ Beat | +98.13% | +177.57% | +197.20% |
| 2025-11-14 | Q3 2025 | -2.70 | -4.74 | -75.56% | $1.4M | ❌ Miss | -2.13% | -26.60% | -21.28% |
| 2025-03-31 | Q4 2024 | -0.14 | -0.21 | -50.00% | $2.2M | ❌ Miss | -0.73% | +160.93% | +71.43% |
| 2024-11-14 | Q3 2024 | -0.15 | -0.16 | -6.67% | $2.4M | ❌ Miss | +3.10% | -1.55% | -27.91% |
| 2024-08-14 | Q2 2024 | — | -0.19 | — | $2.4M | — | +3.49% | -0.58% | -4.07% |
| 2024-05-15 | Q1 2024 | — | -0.21 | — | $2.4M | — | +0.53% | +26.74% | +12.68% |
Showing last 8 quarters.